Physician

Michael T. Warrick

According to 2025 Medicare claims, Michael Warrick (NPI: 1952472953) practices interventional pain management (ipm) in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PRISMA HEALTH MEDICAL GROUP-MIDLANDS (NPI: 1871080283; TIN: 471345819) and primary practice location at 29150-4975. Warrick is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Warrick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 2,775 HCPCS/CPT codes, and received $194,583 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,716 prescription claims across 340 beneficiaries totaling $178,865 in drug costs, led by Levorphanol Tartrate (Levorphanol Tartrate). 2019 DME data shows 16 claims. Open Payments data shows 17 records totaling $6,784. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $152,504 and ending at $178,865. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,464 and ending at $924.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	686	3,381	$188,491
2016	703	2,974	$174,508
2017	689	2,963	$180,926
2018	648	2,997	$191,602
2019	744	3,205	$211,808
2020	607	2,361	$164,890
2021	545	2,217	$157,049
2022	562	1,912	$138,482
2023	549	2,520	$169,402
2024	510	2,775	$194,583

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	330	2,695	$152,504
2016	374	2,974	$196,495
2017	367	3,225	$190,090
2018	380	3,325	$211,328
2019	346	2,391	$139,717
2020	327	2,010	$104,535
2021	287	1,159	$49,593
2022	289	1,253	$83,411
2023	330	2,023	$193,241
2024	340	2,716	$178,865

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$1,355
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	16	$603
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	159	159	$98
62321	Injection of substance into middle or upper spine canal using imaging guidance	94	188	$79
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	281	470	$77
62323	Injection of substance into lower spine canal using imaging guidance	267	610	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	325	530	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Levorphanol Tartrate	Levorphanol Tartrate	12	360	$57,669
Xtampza Er	Oxycodone Myristate	25	697	$17,209
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	754	21,777	$16,663
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	685	19,646	$14,985
Oxymorphone Hcl Er	Oxymorphone Hcl	24	720	$11,176

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$6,784	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael T. Warrick?

Tedicare shows public-source Medicare data for Michael T. Warrick (NPI 1952472953), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael T. Warrick have ACO affiliation data?

Michael T. Warrick is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Michael T. Warrick?

Michael T. Warrick is linked to PRISMA HEALTH MEDICAL GROUP-MIDLANDS (billing NPI 1871080283) in the available physician profile data.

Does Michael T. Warrick have Open Payments data?

Michael T. Warrick has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.